Share on StockTwits

BioDrain Medical (NASDAQ:SKLN) major shareholder Samuel Herschkowitz purchased 25,000 shares of BioDrain Medical stock on the open market in a transaction that occurred on Wednesday, July 23rd. The stock was purchased at an average price of $0.13 per share, for a total transaction of $3,250.00. Following the acquisition, the insider now directly owns 46,780,377 shares of the company’s stock, valued at approximately $6,081,449. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Shares of BioDrain Medical (NASDAQ:SKLN) opened at 0.13 on Friday. BioDrain Medical has a 52 week low of $0.106 and a 52 week high of $0.47. The stock’s 50-day moving average is $0.15 and its 200-day moving average is $0.1. The company’s market cap is $28.9 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.